MedFilo
Healthcare Software · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
441 Lexington Ave, New York, New York, 1...Website
www.medfilo.comRevenue
<$5 MillionIndustry
About MedFilo
MedFilo Org Chart
Is MedFilo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if MedFilo had a recent Job posting/layoffs
MedFilo, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if MedFilo is spiking on competitors!
Funding: Get notified immidiatlly once MedFilo has new funding data
Congratulate Masked Content for being promoted to Masked Content at MedFilo
Check if MedFilo has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when MedFilo launches new products
Earning: See what the market has to say on MedFilo recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
MedFilo is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
MedFilo is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about MedFilo.
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MedFilo
MedFilo is a digital platform that provides users with secure access to their health data, including vaccination records and verified STI testing results. The app is designed for individual users, universities, enterprises, and the health community, empowering them to manage and share their health information confidently. MedFilo aims to create saf... Read More